Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide

Leukemia

Volumn 12, Issue 9, 1998, Pages 1461-1466

  Shami, P J ^a   Sauls, D L ^b   Weinberg, J B ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell growth; Leukemia; Nitric oxide; NO donor

Indexed keywords

NITRIC OXIDE;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 0031708775     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401131     Document Type: Article

References (23)

1. Moncada S, Palmer RMJ, Higgs EA. NO: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
2. Nathan C. NO as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
3. Knowles RG, Moncada S. NO synthase in mammals. Biochem J 1994; 298: 249-258.
4. Nathan C, Xie Q. NO synthases: roles, tolls, and controls. Cell 1994; 78: 915-919.
5. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87-94.
6. Shimaoka M, Iida T, Ohara A, Taenaka N, Mashimo T, Honda T, Yoshiya I. NOC, a NO-releasing compound, induces dose-dependent apoptosis in macrophages. Biochem Biophys Res Commun 1995; 209: 519-526.
7. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993; 150: 5080-5085.
8. Magrinat C, Mason SN, Shami PJ, Weinberg JB. NO modulation of human leukemia cell differentiation and gene expression. Blood 1992; 80: 1980-1986.
9. Shami PJ, Gockerman JP, Hathorn JW, Moore JO, Misukonis MA, Weinberg JB. Effect of NO on the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells. Leukemia Res 1995; 19: 527-533.
10. Shami PJ, Weinberg JB. Differential effects of NO on erythroid and myeloid colony growth from CD34-positive human bone marrow cells. Blood 1996; 87: 977-983.
11. Keefer LK, Nims RW, Davies KM, Wink DA. 'NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Meth Enzymol 1996; 268: 281-293.
12. Nicoletti I, Migliorati C, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 1991; 139: 271-279.
13. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyc W, Hotz MA, Lassota P, Tragano F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795-608.
14. Mooradian DL, Hutsell TC, Keefer LK. NO (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 1995; 25: 674-678.
15. Henry Y, Lepoivre M, Drapier JC, Ducrocz C, Boucher JL, Guissani A. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J 1993; 7: 1124-1134.
16. Lincoln TM, Cornwell TL, Komalavilas P, Boerth N. Cyclic GMP-dependent protein kinase in nitric oxide signaling. Meth Enzymol 1996; 269: 149-166.
17. Brüne B, Mohr S, Messmer UK. Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide signaling pathways. Rev Physiol Biochem Pharmacol 1996; 127: 1-30.
18. Geng YJ, Hellstrand K, Wennmalm A, Hansson GK. Apoptotic death of human leukemia cells induced by vascular cells expressing nitric oxide synthase in response to gamma-interferon and tumor necrosis factor-alpha. Cancer Res 1996; 56: 866-874.
19. Messmer UK, Brüne B. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signaling pathways. Biochem J 1995; 319: 299-305.
20. Kuo ML, Chau YP, Wang JH, Shiah SG. Inhibitors of poly(ADP-ribose) polymerase block nitric oxide-induced apoptosis but not differentiation in human leukemia HL-60 cells. Biochem Biophys Res Commun 1996; 219: 502-508.
21. Lin KT, Xue JY, Nomen M, Spur B, Wong PYK. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 1995; 270: 16487-16490.
22. Genaro AM, Hortelano S, Alvarez A, Martinez-AC, Boscà L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained bcl-2 levels. J Clin Invest 1995; 95: 1884-1890.
23. Saavedra JE, Billiar TR, Williams DL, Kim YM, Watkins SC, Keefer LK. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J Med Chem 1997; 40: 1947-1954.